Kymera Therapeutics, Inc.

NasdaqGM:KYMR Stock Report

Market Cap: US$2.1b

Kymera Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:KYMR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Mar 25SellUS$214,219Bruce JacobsIndividual7,035US$31.00
03 Mar 25SellUS$68,239Ellen ChiniaraIndividual2,241US$31.00
03 Mar 25SellUS$174,786Jared GollobIndividual5,740US$31.00
03 Mar 25SellUS$42,113Jeremy ChadwickIndividual1,383US$31.00
06 Jan 25SellUS$130,645Ellen ChiniaraIndividual3,129US$41.75
20 Aug 24BuyUS$46Baker Bros. Advisors LPCompany1US$46.41
09 Jul 24SellUS$3,010,224Atlas Venture L.P.Company78,776US$39.26
12 Jun 24SellUS$102,973Atlas Venture L.P.Company2,905US$36.02
23 May 24SellUS$90,105Jeremy ChadwickIndividual2,575US$34.99

Insider Trading Volume

Insider Buying: KYMR insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of KYMR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders898,7781.24%
VC/PE Firms4,896,4626.74%
Hedge Funds16,307,73022.4%
Institutions50,554,18169.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 96.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.6%
T. Rowe Price Group, Inc.
6,870,333US$223.6m3.38%0.02%
9.23%
Baker Bros. Advisors LP
5,995,929US$195.1m0%2.03%
8.17%
Wellington Management Group LLP
5,307,326US$172.7m14.9%0.03%
7.95%
BVF Partners L.P.
5,161,801US$168.0m0%6.86%
7.93%
Avoro Capital Advisors LLC
5,150,000US$167.6m14.4%2.43%
7.54%
Atlas Venture L.P.
4,896,462US$159.3m0%27.01%
7.53%
The Vanguard Group, Inc.
4,887,312US$159.0m2.81%no data
7.44%
FMR LLC
4,830,397US$157.2m-5.46%0.01%
6.71%
BlackRock, Inc.
4,356,303US$141.8m3.43%no data
4.57%
Invus Financial Advisors, LLC
2,969,733US$96.6m0%5.35%
2.6%
State Street Global Advisors, Inc.
1,688,789US$55.0m-2.28%no data
2.14%
Driehaus Capital Management LLC
1,390,372US$45.2m4.64%0.31%
1.7%
Geode Capital Management, LLC
1,105,487US$36.0m4.96%no data
1.69%
Redmile Group, LLC
1,100,432US$35.8m-21%2.73%
1.59%
Rock Springs Capital Management LP
1,034,137US$33.7m-1.45%1.41%
1.35%
UBS Asset Management AG
874,509US$28.5m35.3%no data
1.19%
MRL Ventures Fund LLC
772,165US$25.1m0%19.11%
1.1%
Jennison Associates LLC
716,933US$23.3m-10.1%0.02%
1.02%
Nello Mainolfi
659,959US$21.5m1.54%no data
0.91%
Deerfield Management Company, L.P. Series C
593,000US$19.3m0%0.42%
0.83%
Woodline Partners LP
537,428US$17.5m2.35%0.13%
0.77%
Avidity Partners Management, L.P.
500,000US$16.3m0%1.86%
0.7%
Eventide Asset Management, LLC
455,728US$14.8m-10.3%0.29%
0.67%
Northern Trust Global Investments
437,833US$14.2m14%no data
0.67%
Dimensional Fund Advisors LP
433,755US$14.1m-8.22%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/23 23:59
End of Day Share Price 2025/03/21 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kymera Therapeutics, Inc. is covered by 26 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhiqiang ShuBerenberg
Tazeen AhmadBofA Global Research
Kalpit PatelB. Riley Securities, Inc.